Rivastigmine (Mechanism of Action)
Rivastigmine is a medication used primarily to treat dementia associated with Alzheimer’s disease and Parkinson’s disease. It belongs to a class of drugs known as cholinesterase inhibitors, which work by enhancing the function of nerve cells in the brain. Here’s a more detailed overview:
Mechanism of Action: Rivastigmine inhibits the enzymes acetylcholinesterase and butyrylcholinesterase, which are responsible for breaking down acetylcholine in the brain. Acetylcholine is a neurotransmitter that plays a crucial role in memory, thinking, and reasoning. By preventing its breakdown, rivastigmine increases the concentration of acetylcholine, helping to improve cognitive function in patients with dementia.